Utilizing cell population data for diagnosis and intensive care unit requirement prediction in Fournier gangrene patients
Author:
Saygın Hüseyin1ORCID, Bolat Serkan2ORCID, Asdemir Aydemir1ORCID, Öztürk Abuzer3ORCID, Ergin İsmail E.4ORCID, Doğan Halef O.2ORCID, Korgalı Esat1ORCID
Affiliation:
1. Department of Urology , 63986 Sivas Cumhuriyet University Faculty of Medicine , Sivas , Türkiye 2. Department of Medical Biochemistry , Sivas Cumhuriyet University Faculty of Medicine , Sivas , Türkiye 3. Department of Urology , Sivas Numune Hospital , Sivas , Türkiye 4. Department of Urology , Ankara Kızılcahamam State Hospital , Ankara , Türkiye
Abstract
Abstract
Objectives
It is vital to rapid diagnosis and to determine the intensive care unit (ICU) requirement early to reduce the mortality rate in Fournier gangrene (FG) patients. Cell population data (CPD) are the parameters obtained from complete blood count (CBC) analysis and related to the activation of different leukocyte subgroups. The study aimed to find reliable markers to diagnose and determine the ICU requirement using CPD.
Methods
We included 24 patients and 22 healthy controls in the study. CBC analyses were performed by using a Sysmex XN-9000 series hematology analyzer. ROC analyses and group comparisons were performed to evaluate the diagnostic accuracy and prognostic value of CPD parameters in ICU requirements.
Results
Statistically significant differences were observed in terms of some CPD values of lymphocytes, neutrophils, and monocytes in patients compared to healthy controls. Neutrophile-Y or reactivity index (Ne-Y or RI) (p=0.004), neutrophile-X or granularity index (Ne-X or GI) (p=0.009), monocyte-X (Mo-X) (p<0.001), and lymphocyte-WY (Ly-WY) (p<0.001) were higher in patients than controls. Ne-Y (RI) (p=0.012), Mo-X (p=0.001), Mo-Y (p=0.022), and Ne-WY (p=0.025) levels were higher in ICU patients than in non-ICU patients.
Conclusions
The severity of FG disease can be determined using CPD data. Ne-Y (RI) serves as a novel and reliable biomarker for determining disease severity. In addition, the neutrophile-lymphocyte ratio can be used to rule out FG, especially in combination with other well-known clinical and diagnostic parameters.
Publisher
Walter de Gruyter GmbH
Reference17 articles.
1. Norton, KS, Johnson, LW, Perry, T, Perry, KH, Sehon, JK, Zibari, GB. Management of Fournier’s gangrene: an eleven year retrospective analysis of early recognition, diagnosis, and treatment. Am Sur 2002;68:709–13. https://doi.org/10.1177/000313480206800810. 2. Lin, TY, Cheng, IH, Ou, CH, Tsai, YS, Tong, YC, Cheng, HL, et al.. Incorporating simplified Fournier’s gangrene severity index with early surgical intervention can maximize survival in high-risk Fournier’s gangrene patients. Int Journal Urol 2019;26:737–43. https://doi.org/10.1111/iju.13989. 3. Chennamsetty, A, Khourdaji, I, Burks, F, Killinger, KA. Contemporary diagnosis and management of Fournier’s gangrene. Ther Adv Urol 2015;7:203–15. https://doi.org/10.1177/1756287215584740. 4. Atakan, IH, Kaplan, M, Kaya, E, Aktoz, T, Inci, O. A life-threatening infection: Fournier’s gangrene. Int Urol Nephrol 2002;34:387–92. https://doi.org/10.1023/a:1024427418743. 5. Üreyen, O, Acar, A, Gökçelli, U, Atahan, MK, İlhan, E. Usefulness of FGSI and UFGSI scoring systems for predicting mortality in patients with Fournier’s gangrene: a multicenter study. Ulus Travma Acil Cerrahi Derg 2017;23:389–94. https://doi.org/10.5505/tjtes.2017.71509.
|
|